CRBP
Corbus Pharmaceuticals Holding
5.80$
-1.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -716.8% | -710.0% | -1,139.1% | -623.5% | -126.5% | -2,531.9% | -5,464.8% | – | – | – | – | |
| – | – | – | 6.8% | 4.6% | 10.5% | 10.2% | 3.4% | 43.0% | 185.9% | – | – | – | – | |
| – | – | – | 177.9% | 165.5% | 233.4% | 157.8% | 33.2% | 316.4% | 1,075.2% | – | – | – | – | |
| – | – | – | 177.6% | 166.2% | 233.0% | 159.3% | 33.3% | 325.2% | 1,226.4% | – | – | – | – | |
| – | – | – | 463.9% | 161.5% | -91.4% | 352.7% | 34.5% | -81.4% | -1,780.2% | – | – | – | – | |
| – | – | – | 17.6% | 18.5% | 29.0% | 47.7% | 7.6% | 12.3% | 6.1% | – | – | – | – | |
| – | – | – | -17.6% | -18.5% | -29.0% | -47.7% | -7.6% | -12.3% | -8,326.7% | – | – | – | – | |
| – | – | – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | 1,747.3% | 873.6% | 3,233.0% | 249.9% | 112.5% | 3,611.7% | – | – | – | – | – | |
| – | – | – | -75.8% | 2.2% | -118.2% | -13.1% | -8.8% | 475.3% | 6.6% | – | – | – | – | |
| – | – | – | 1,671.4% | 875.9% | 3,114.8% | 236.8% | 106.4% | 3,933.6% | 6,898.4% | – | – | – | – | |
| – | – | – | 937.1% | 147.4% | 1,946.7% | -434.4% | -27.7% | 1,372.4% | -6,893.1% | – | – | – | – | |
| – | – | – | -734.4% | -728.5% | -1,168.1% | -671.2% | -134.1% | -2,544.2% | -5,471.0% | – | – | – | – |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.